The Experts below are selected from a list of 408 Experts worldwide ranked by ideXlab platform
Anthony C. Venbrux - One of the best experts on this subject based on the ideXlab platform.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
embolization of the ovarian veins as a treatment for patients with chronic Pelvic pain caused by Pelvic venous incompetence Pelvic Congestion Syndrome
Current Opinion in Obstetrics & Gynecology, 1999Co-Authors: Anthony C. Venbrux, Drew L LambertAbstract:Ovarian and Pelvic (internal iliac) varices have long been recognized as a source of chronic Pelvic pain in women. The technique of transcatheter embolotherapy for ovarian and Pelvic varices requires selective catheterization of the ovarian and internal iliac veins, followed by contrast venography and embolization. The long-term effects of treatment are the subject of ongoing investigation. This article provides a concise background on ovarian and Pelvic varices and reviews the recently published literature on their embolization for the treatment of Pelvic venous incompetence (also known as Pelvic Congestion Syndrome).
Drew L Lambert - One of the best experts on this subject based on the ideXlab platform.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
embolization of the ovarian veins as a treatment for patients with chronic Pelvic pain caused by Pelvic venous incompetence Pelvic Congestion Syndrome
Current Opinion in Obstetrics & Gynecology, 1999Co-Authors: Anthony C. Venbrux, Drew L LambertAbstract:Ovarian and Pelvic (internal iliac) varices have long been recognized as a source of chronic Pelvic pain in women. The technique of transcatheter embolotherapy for ovarian and Pelvic varices requires selective catheterization of the ovarian and internal iliac veins, followed by contrast venography and embolization. The long-term effects of treatment are the subject of ongoing investigation. This article provides a concise background on ovarian and Pelvic varices and reviews the recently published literature on their embolization for the treatment of Pelvic venous incompetence (also known as Pelvic Congestion Syndrome).
Courtland J Robinson - One of the best experts on this subject based on the ideXlab platform.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
Diana F Barron - One of the best experts on this subject based on the ideXlab platform.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
Andrew H Chang - One of the best experts on this subject based on the ideXlab platform.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
-
Pelvic Congestion Syndrome Pelvic venous incompetence impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic Pelvic pain
Journal of Vascular and Interventional Radiology, 2002Co-Authors: Anthony C. Venbrux, Andrew H Chang, Brian J Montague, Aravind Arepally, Peter C Rowe, Diana F Barron, Drew L Lambert, J. Hebert, Courtland J RobinsonAbstract:PURPOSE The purpose of this study was to analyze the impact of transcatheter embolotherapy on pain perception and menstrual cycle in women with chronic Pelvic pain caused by the presence of ovarian and Pelvic varices (ie, women with Pelvic Congestion Syndrome or Pelvic venous incompetence). MATERIALS AND METHODS From July 1998 to August 2000, 56 patients (mean age, 32.3 y) were treated for chronic Pelvic pain. Diagnostic venography of the ovarian veins was followed by transcatheter embolotherapy with a sclerosing agent and coils. A second session was completed to embolize the internal iliac veins in 43 of 56 patients. Visual analog scales (VAS) used to measure pain were administered before embolization and at 3-, 6-, and 12-month follow-up. Questionnaires regarding menstrual history were used as part of the postprocedural analysis. RESULTS Percutaneous transcatheter embolotherapy of ovarian and Pelvic varices was technically successful in 56 of 56 patients (100%); three patients developed recurrent varices, two of whom were treated with repeat transcatheter embolotherapy. Two patients, early in the experience, had complications in which coils placed in the internal iliac veins embolized to the pulmonary circulation; the coils were snared without clinical sequelae. On the VAS, the mean baseline pain level was 7.8 (range, 3.2–9.8; n = 56); at 3-month follow-up, it was 4.2 (range, 0.0–7.2; n = 56); at 6 months, 3.8 (range, 0.0–6.7; n = 41); and at 12 months, 2.7 (range, 0.0–6.9; n = 32). Differences were significant ( P CONCLUSION For patients with ovarian/internal iliac varices, transcatheter embolotherapy provides a nonsurgical treatment option. There is a significant decrease in pain based on VAS without any notable impact on menstrual cycle.
